Article

Aberrant Fucosylation of Saliva Glycoprotein Defining Lung Adenocarcinomas Malignancy

2021-12-17

Abstract excerpt

Aberrant glycosylation is a hallmark of cancer found during tumorigenesis and tumor progression. Lung cancer induced by oncogene mutations has been detected in the patient’s saliva, and saliva glycosylation has been altered. Saliva contains highly glycosylated glycoproteins, the characteristics of which may be related to various diseases. Therefore, elucidating cancer-specific glycosylation in the saliva of health...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 28f32773-ab81-5bd6-b146-0f80e9425c1e
DOI: 10.1101/2021.12.16.472888

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Aberrant Fucosylation of Saliva Glycoprotein Defining Lung Adenocarcinomas MalignancyDOI 10.1101/2021.12.16.472888Read

Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueSemantic proximity Read

Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosis.Semantic proximity Read

Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeuticsSemantic proximity Read

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinomaSemantic proximity Read

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastomaSemantic proximity Read

Chemical proteomic approach for in-depth glycosylation profiling of plasma carcinoembryonic antigen in cancer patientsSemantic proximity Read

Quantitative Glycoproteomics Analysis Reveals Changes in N-Glycosylation Level Associated with Pancreatic Ductal AdenocarcinomaSemantic proximity Read

Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer typesSemantic proximity Read

Quantitative Serum Glycomics of Esophageal Adenocarcinoma and Other Esophageal Disease OnsetsSemantic proximity Read

Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis.Semantic proximity Read

Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapySemantic proximity Read

Evaluation of the serum <b> <i>N</i> </b> ‐linked glycome for the diagnosis of cancer and chronic inflammationSemantic proximity Read